Verona Pharma Drug Patent Portfolio
Verona Pharma owns 1 orange book drug protected by 4 US patents Given below is the list of Verona Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12251384 | Particulate composition | 25 Jun, 2044 | Active |
| US10945950 | Liquid inhalation formulation comprising RPL554 | 15 Sep, 2035 | Active |
| US9956171 | Liquid inhalation formulation comprising RPL554 | 15 Sep, 2035 | Active |
| US9062047 | Crystalline form of pyrimido[6,1-A] isoquinolin-4-one compound | 21 Aug, 2031 | Active |
Verona Pharma's Family Patents
Verona Pharma Drug List
Given below is the complete list of Verona Pharma's drugs and the patents protecting them.
1. Ohtuvayre
Ohtuvayre is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12251384 | Particulate composition |
25 Jun, 2044
(19 years from now)
| Active |
| US10945950 | Liquid inhalation formulation comprising RPL554 |
15 Sep, 2035
(10 years from now)
| Active |
| US9956171 | Liquid inhalation formulation comprising RPL554 |
15 Sep, 2035
(10 years from now)
| Active |
| US9062047 | Crystalline form of pyrimido[6,1-A] isoquinolin-4-one compound |
21 Aug, 2031
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ohtuvayre's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List